| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| (Ala11·22·28)-VIP (human, mouse, rat) |
HIS-SER-ASP-ALA-VAL-PHE-THR-ASP-ASN-TYR-ALA-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-ALA-LEU-ASN-SER-ILE-LEU-ALA-NH2 |
291524-04-4 |
詳細(xì)
|
| (Arg8)-Vasopressin (4-9) |
GLN-ASN-CYS-PRO-ARG-GLY-NH2 |
96027-30-4 |
詳細(xì)
|
| (Deamino-Cys1,Val4,D-Arg8)-Vasopressin |
(DEAMINO-CYS1,VAL4,D-ARG8)-VASOPRESSIN |
43157-23-9 |
詳細(xì)
|
| Gly-Neuroendocrine Regulatory Peptide-3 (human, mouse, rat) |
GLY-NEUROENDOCRINE REGULATORY PEPTIDE-3 |
1815618-19-9 |
詳細(xì)
|
| HHV-2 Envelope Glycoprotein G (552-574) |
HHV-2 ENVELOPE GLYCOPROTEIN G (552-574) |
2022956-63-2 |
詳細(xì)
|
| Ac-Ala-Ala-Ala-Ala-OMe |
AC-ALA-ALA-ALA-ALA-OME |
30802-29-0 |
詳細(xì)
|
| Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) |
ACETYL-(D-PHE2,LYS1,ARG1,LEU2)-VIP (1-7)-GRF (8-27) |
202463-00-1 |
詳細(xì)
|
| VIP sulfoxide (human, mouse, rat) |
VIP SULFOXIDE (HUMAN, BOVINE, PORCINE, RAT) |
95050-90-1 |
詳細(xì)
|
| LQEQ-19 (mouse, rat) |
LQEQ-19 |
322644-72-4 |
詳細(xì)
|
| AQEE-30 (human) |
AQEE-30 |
160046-70-8 |
詳細(xì)
|
| VIP Receptor-Binding Inhibitor L-8-K |
TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2: YTRLRKQMAVKKYLNSILN-NH2 |
120550-85-8 |
詳細(xì)
|
| (d(CH2)51,D-Phe2,Ile4,Ala-NH29)-Vasopressin |
(d(CH)1,D-Phe2,Ile,Ala-NH)-Vasopressin |
99835-78-6 |
詳細(xì)
|
| Hexanoyl-(Ala19,Lys27.28)-VIP (free acid) |
HEXANOYL-(ALA1,LYS22)-VIP |
1926163-31-6 |
詳細(xì)
|
| Tertiapin |
tertiapin |
58694-52-3 |
詳細(xì)
|
| VIP (6-28) (human, mouse, rat) |
PHE-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2 |
69698-54-0 |
詳細(xì)
|
| Ac-Ala-Ala-Ala-OMe |
N-乙酰基-L-丙氨?；?L-丙氨酰基-L-丙氨酸甲酯 |
26910-17-8 |
詳細(xì)
|
| AQEE-30 (mouse, rat) |
AQEE-30 |
323185-80-4 |
詳細(xì)
|
| Urotensin II (human) |
UROTENSIN II (HUMAN) |
251293-28-4 |
詳細(xì)
|
| H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-Lys-Val-Cys-p-chloro-Phe-NH2 (Disulfide bond) |
H-P-CHLORO-PHE-D-CYS-Β-(3-PYRIDYL)-ALA-D-TRP-LYS-VAL-CYS-P-CHLORO-PHE-NH |
209006-05-3 |
詳細(xì)
|
| (1-Adamantaneacetyl1,D-Tyr(Et)2,Val4,Abu6, Arg8.9)-Vasopressin |
(1-ADAMANTANEACETYL1,D-TYR(ET)2,VAL,ABU, ARG)-VASOPRESSIN |
112465-00-6 |
詳細(xì)
|
| Ac-Ala-Ala-Ala-Ala-OH |
AC-ALA-ALA-ALA-ALA-OH |
15483-58-6 |
詳細(xì)
|
| VIP (guinea pig) |
VIP (GUINEA PIG) |
96886-24-7 |
詳細(xì)
|
| Stichodactyla helianthus Neurotoxin (ShK) |
地毯?？舅?/td>
| 172450-46-3 |
詳細(xì)
|
| (d(CH2)51,D-Tyr(Et)2,Val4,Arg8,des-Gly9)-Vasopressin |
(D(CH2)51,D-TYR(ET)2,VAL4,ARG8,DES-GLY9)-VASOPRESSIN |
90332-82-4 |
詳細(xì)
|
| Copeptin (human) |
和肽素 |
78362-34-2 |
詳細(xì)
|
| Tertiapin-Q |
托肽品 Q |
910044-56-3 |
詳細(xì)
|
| (Lys8)-Vasopressin |
賴氨加壓素 |
50-57-7 |
詳細(xì)
|
| (d(CH2)51,D-Ile2,Ile4,Arg8)-Vasopressin |
(D(CH2)51,D-ILE2,ILE4,ARG8)-VASOPRESSIN |
88686-53-7 |
詳細(xì)
|
| Vesicular Stomatitis Virus Nucleoprotein (52-59) |
VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN (52-59) |
132326-74-0 |
詳細(xì)
|
| Urotensin II-Related Peptide (human, mouse, rat) |
UROTENSIN II-RELATED PEPTIDE (HUMAN, MOUSE, RAT) |
342878-90-4 |
詳細(xì)
|
| (Dap22)-Stichodactyla helianthus Neurotoxin (ShK) |
(DAP22)-STICHODACTYLA HELIANTHUS NEUROTOXIN (SHK) |
220384-25-8 |
詳細(xì)
|
| (Deamino-Cys1,D-Orn8)-Vasopressin |
(DEAMINO-CYS1,D-ORN8)-VASOPRESSIN |
60498-04-6 |
詳細(xì)
|
| (Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin |
(PHENYLAC1,D-TYR(ET)2,LYS6,ARG8,DES-GLY9)-VASOPRESSIN |
129520-65-6 |
詳細(xì)
|
| FITC-εAhx-HHV-2 Envelope Glycoprotein G (561-578) |
FITC-εAhx-HHV-2 Envelope Glycoprotein G (561-578) |
2022956-64-3 |
詳細(xì)
|
| Ac-Ala-Ala-OMe |
AC-ALA-ALA-OME |
30802-26-7 |
詳細(xì)
|
| Urotensin II (goby) |
UROTENSIN II |
9047-55-6 |
詳細(xì)
|
| (D-Phe2)-VIP (human, mouse, rat) |
(D-PHE2)-VIP (HUMAN, BOVINE, PORCINE, RAT) |
104051-15-2 |
詳細(xì)
|
| Neuroendocrine Regulatory Peptide-4 (human, mouse, rat) |
NEUROENDOCRINE REGULATORY PEPTIDE-4 |
922704-18-5 |
詳細(xì)
|
| Myristoyl-(Lys12.27.28)-VIP-Gly-Gly-Thr (free acid) |
MYR-HIS-SER-ASP-ALA-VAL-PHE-THR-ASP-ASN-TYR-THR-LYS-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LYS-LYS-GLY-GLY-THR-OH |
|
詳細(xì)
|
| Terlipressin |
特利加壓素 |
14636-12-5 |
詳細(xì)
|
| (Deamino-Cys1,β-cyclohexyl-Ala4,Arg8)-Vasopressin |
(DEAMINO-CYS1,Β-CYCLOHEXYL-ALA,ARG)-VASOPRESSIN |
500170-27-4 |
詳細(xì)
|
| Neuroendocrine Regulatory Peptide-2 (human) |
NEUROENDOCRINE REGULATORYPEPTIDE-2 |
1872441-23-0 |
詳細(xì)
|
| Boc-Pressinoic acid |
BOC-PRESSINOIC ACID |
72287-67-3 |
詳細(xì)
|
| TLQP-21 (human) |
TLQP-21 |
1259837-37-0 |
詳細(xì)
|
| (p-Chloro-D-Phe6,Leu17)-VIP (human, mouse, rat) |
(P-CHLORO-D-PHE6,LEU17)-VIP (HUMAN, BOVINE, PORCINE, RAT) |
102805-45-8 |
詳細(xì)
|
| Ac-Met-Asp-Lys-Val-Leu-Asn-Arg-Glu-OH |
AC-MET-ASP-LYS-VAL-LEU-ASN-ARG-GLU-OH |
287193-38-8 |
詳細(xì)
|
| (d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin |
(D(CH2)51,TYR(ME)2,ARG8)-VASOPRESSIN |
73168-24-8 |
詳細(xì)
|
| Biotinyl-VIP (human, mouse, rat) |
BIOTINYL-VIP |
1815618-13-3 |
詳細(xì)
|
| (Deamino-Cys1,D-Arg8)-Vasopressin |
去氨加壓素 |
16679-58-6 |
詳細(xì)
|
| (Propionyl1,D-Tyr(Et)2,Val4,Abu6,Arg8·9)-Vasopressin |
(PROPIONYL1,D-TYR(ET)2,VAL4,ABU6,ARG8·9)-VASOPRESSIN |
121250-95-1 |
詳細(xì)
|
| (Lys4)-Sarafotoxin C |
(LYS)-SARAFOTOXIN C |
1219444-22-0 |
詳細(xì)
|
| (d(CH2)51,Tyr(Et)2,Val4,Arg8,des-Gly9)-Vasopressin |
(D(CH2)51,TYR(ET)2,VAL4,ARG8,DES-GLY9)-VASOPRESSIN |
90332-81-3 |
詳細(xì)
|
| Urotensin I |
硬骨魚緊張肽 |
83930-33-0 |
詳細(xì)
|
| Neuroendocrine Regulatory Peptide-1 (rat) |
NEUROENDOCRINE REGULATORY PEPTIDE-1 (RAT) |
954420-51-0 |
詳細(xì)
|
| Copeptin (rat) |
COPEPTIN (RAT) |
86280-64-0 |
詳細(xì)
|
| Toxin GaTx1 |
TOXIN GATX1 |
1926163-15-6 |
詳細(xì)
|
| HTLV-1 Tax (11-19) |
HTLV-1 TAX (11-19) |
141677-18-1 |
詳細(xì)
|
| HSV-1 Glycoprotein (gB) (497-507) |
THR-SER-SER-ILE-GLU-PHE-ALA-ARG-LEU-GLN-PHE |
148337-11-5 |
詳細(xì)
|
| PHM-27 (human) |
聚六亞甲基雙弧 |
87403-73-4 |
詳細(xì)
|
| Biotinyl-(Arg8)-Vasopressin |
BIOTINYL-(ARG8)-VASOPRESSIN |
126703-17-1 |
詳細(xì)
|
| Influenza PR8 Hemagglutinin Peptide (110-119) |
SER-PHE-GLU-ARG-PHE-GLU-ILE-PHE-PRO-LYS |
132031-50-6 |
詳細(xì)
|
| H-Ala-Lys-Leu-Arg-Glu-Arg-Leu-Lys-Gln-Arg-Gln-Gln-Leu-Gln-Asn-Arg-Arg-Gly-Leu-Asp-Ile-Leu-Phe-Leu-Gln-Glu-Gly-Gly-Leu-OH |
H-ALA-LYS-LEU-ARG-GLU-ARG-LEU-LYS-GLN-ARG-GLN-GLN-LEU-GLN-ASN-ARG-ARG-GLY-LEU-ASP-ILE-LEU-PHE-LEU-GLN-GLU-GLY-GLY-LEU-OH |
126947-95-3 |
詳細(xì)
|
| Ac-Ala-Ala-Ala-OH |
N-乙?；?L-丙氨酰-L-丙氨酰-L-丙氨酸 |
19245-85-3 |
詳細(xì)
|
| (3-(4-Azidophenyl)propionyl1,D-Tyr(Me)2,Arg6,Arg8,Tyr-NH29)-Vasopressin |
(3-(4-AZIDOPHENYL)PROPIONYL1,D-TYR(ME)2,ARG6,ARG8,TYR-NH29)-VASOPRESSIN |
157702-46-0 |
詳細(xì)
|
| 6-FAM-AEEAc-Stichodactyla helianthus Neurotoxin (ShK) |
6-FAM-AEEAC-STICHODACTYLA HELIANTHUS NEUROTOXIN (SHK) |
1927927-42-1 |
詳細(xì)
|
| Acetyl-Neurotrophin Receptor (368-381) amide (human) |
ACETYL-NEUROTROPHIN RECEPTOR (368-381) AMIDE (HUMAN) |
197230-90-3 |
詳細(xì)
|
| (Deamino-Pen1,Val4,D-Arg8)-Vasopressin |
(DEAMINO-PEN1,VAL4,D-ARG8)-VASOPRESSIN |
64158-84-5 |
詳細(xì)
|
| (Pen5)-Urotensin II (4-11) (human) |
(PEN)-UROTENSIN II (4-11) |
473902-31-7 |
詳細(xì)
|
| TLQP-21 (mouse, rat) |
TLQP-21 |
869988-94-3 |
詳細(xì)
|
| Matrix Protein M1 (58-66) (Influenza A virus) |
GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU |
141368-69-6 |
詳細(xì)
|
| (d(CH2)51,D-Ile2,Ile4,Arg8,Ala-NH29)-Vasopressin |
(D(CH2)51,D-ILE2,ILE4,ARG8,ALA-NH29)-VASOPRESSIN |
114455-29-7 |
詳細(xì)
|
| Pre-S2 (1-26) |
MET-GLN-TRP-ASN-SER-THR-ALA-PHE-HIS-GLN-THR-LEU-GLN-ASP-PRO-ARG-VAL-ARG-GLY-LEU-TYR-LEU-PRO-ALA-GLY-GLY |
104753-45-9 |
詳細(xì)
|
| Neuroendocrine Regulatory Peptide-2 (rat) |
NEUROENDOCRINE REGULATORY PEPTIDE-2 |
1872441-24-1 |
詳細(xì)
|
| (Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) |
(LYS1,ARG1,LEU2)-VIP (1-7)-GRF (8-27) |
201995-58-6 |
詳細(xì)
|
| (Pyr16)-VIP (16-28) (human, mouse, rat) |
(PYR16)-VIP (16-28) (HUMAN, BOVINE, PORCINE, RAT) |
134907-86-1 |
詳細(xì)
|
| PHI-27 (rat) |
PHI-27 FROM RAT |
96849-38-6 |
詳細(xì)
|
| (Deamino-Cys1,Leu4,Lys8)-Vasopressin |
(DEAMINO-CYS1,LEU,LYS)-VASOPRESSIN |
42061-33-6 |
詳細(xì)
|
| Ac-Gln-Gln-OH |
AC-GLN-GLN-OH |
69624-04-0 |
詳細(xì)
|
| (d(CH2)51,Tyr(Et)2,Val4,Arg8,des-Gly-NH29)-Vasopressin |
(D(CH2)51,TYR(ET)2,VAL4,ARG8,DES-GLY-NH29)-VASOPRESSIN |
110567-67-4 |
詳細(xì)
|
| (Pyr1)-Urotensin II (rat) |
(PYR1)-UROTENSIN II |
405136-99-4 |
詳細(xì)
|
| (β-Asp3)-VIP (human, mouse, rat) |
(Β-ASP3)-VIP |
1926163-85-0 |
詳細(xì)
|
| (3,5-Diiodo-Tyr2,Arg8)-Vasopressin |
(3,5-DIIODO-TYR2,ARG)-VASOPRESSIN |
63441-67-8 |
詳細(xì)
|
| (Arg8)-Vasopressin (free acid) |
(ARG)-VASOPRESSIN |
25255-33-8 |
詳細(xì)
|
| (Phenylac1,D-Tyr(Me)2,Arg6·8,Tyr-NH29)-Vasopressin |
(PHENYLAC1,D-TYR(ME)2,ARG,TYR-NH)-VASOPRESSIN |
135447-36-8 |
詳細(xì)
|
| PHI-27 (porcine) |
PHI-27 PORCINE |
80458-29-3 |
詳細(xì)
|
| VIP Antagonist |
VIP拮抗劑 |
125093-93-8 |
詳細(xì)
|
| (Arg8)-Vasopressin |
醋酸精氨酸加壓素 |
113-79-1 |
詳細(xì)
|
| VIP (human, mouse, rat) |
醋酸阿肽地爾 |
40077-57-4 |
詳細(xì)
|
| Neuroendocrine Regulatory Peptide-1 (human) |
NEUROENDOCRINE REGULATORY PEPTIDE-1 (HUMAN) |
954420-50-9 |
詳細(xì)
|
| VIP (4-28) (human, mouse, rat) |
VIP (4-28) (HUMAN, BOVINE, PORCINE, RAT) |
64326-02-9 |
詳細(xì)
|
| VIP (3-28) (human, mouse, rat) |
VIP (3-28) (HUMAN, BOVINE, PORCINE, RAT) |
115444-33-2 |
詳細(xì)
|
| (Deamino-Cys1,Lys8)-Vasopressin |
(DEAMINO-CYS1,LYS8)-VASOPRESSIN |
2989-84-6 |
詳細(xì)
|
| Ac-Ala-Ala-OH |
AC-ALA-ALA-OH |
19245-87-5 |
詳細(xì)
|
| Prepro VIP (156-170) (human) |
SER-SER-GLU-GLY-GLU-SER-PRO-ASP-PHE-PRO-GLU-GLU-LEU-GLU-LYS |
107902-86-3 |
詳細(xì)
|
| (Deamino-Pen1,Tyr(Me)2, Arg8)-Vasopressin |
(DEAMINO-PEN1,TYR(ME)2,ARG8)-VASOPRESSIN |
67269-08-3 |
詳細(xì)
|
| (Arg8,des-Gly-NH29)-Vasopressin |
CYS-TYR-PHE-GLN-ASN-CYS-PRO-ARG (DISULFIDE BRIDGE:CYS1-CYS6) |
37552-33-3 |
詳細(xì)
|
| Sarafotoxin C |
CYS-THR-CYS-ASN-ASP-MET-THR-ASP-GLU-GLU-CYS-LEU-ASN-PHE-CYS-HIS-GLN-ASP-VAL-ILE-TRP(DISULFIDE BRIDGE: CYS1-CYS15, CYS3-CYS11) |
121695-87-2 |
詳細(xì)
|
| Ac-Gly-Ala-Val-Ile-Leu-Arg-Arg-NH2 |
|
1092658-86-0 |
詳細(xì)
|
| (Phenylac1,D-Tyr(Me)2,Arg6·8,Lys-NH29)-Vasopressin |
(PHENYLAC1,D-TYR(ME)2,ARG6·8,LYS-NH29)-VASOPRESSIN |
148565-73-5 |
詳細(xì)
|
| (Deamino-Cys1,β-(3-pyridyl)-D-Ala2,Arg8)-Vasopressin |
MPR-D-PYRIDYLALANINE-PHE-GLN-ASN-CYS-PRO-ARG-GLY-NH2 |
136105-89-0 |
詳細(xì)
|